Compare Indoco Remedies with SHARYANS RES. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs CREST VENTURES - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES CREST VENTURES INDOCO REMEDIES/
CREST VENTURES
 
P/E (TTM) x 128.4 4.3 3,011.8% View Chart
P/BV x 2.2 0.4 529.9% View Chart
Dividend Yield % 0.6 0.5 126.4%  

Financials

 INDOCO REMEDIES   CREST VENTURES
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
CREST VENTURES
Mar-18
INDOCO REMEDIES/
CREST VENTURES
5-Yr Chart
Click to enlarge
High Rs317295 107.6%   
Low Rs178135 131.9%   
Sales per share (Unadj.) Rs113.13.7 3,081.0%  
Earnings per share (Unadj.) Rs4.53.6 123.8%  
Cash flow per share (Unadj.) Rs11.83.7 322.9%  
Dividends per share (Unadj.) Rs1.000.50 200.0%  
Dividend yield (eoy) %0.40.2 173.6%  
Book value per share (Unadj.) Rs73.216.4 448.0%  
Shares outstanding (eoy) m92.15260.55 35.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.258.6 3.7%   
Avg P/E ratio x55.559.6 93.1%  
P/CF ratio (eoy) x21.058.8 35.7%  
Price / Book Value ratio x3.413.1 25.7%  
Dividend payout %22.413.9 161.6%   
Avg Mkt Cap Rs m22,83056,018 40.8%   
No. of employees `0005.5NA 30,305.6%   
Total wages/salary Rs m2,209128 1,727.2%   
Avg. sales/employee Rs Th1,910.153,122.2 3.6%   
Avg. wages/employee Rs Th405.07,105.6 5.7%   
Avg. net profit/employee Rs Th75.552,232.8 0.1%   
INCOME DATA
Net Sales Rs m10,419956 1,089.7%  
Other income Rs m476 756.5%   
Total revenues Rs m10,466962 1,087.5%   
Gross profit Rs m1,349652 206.9%  
Depreciation Rs m67713 5,129.5%   
Interest Rs m23580 293.9%   
Profit before tax Rs m484565 85.6%   
Minority Interest Rs m0-7 0.0%   
Prior Period Items Rs m0447 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7265 111.9%   
Profit after tax Rs m412940 43.8%  
Gross profit margin %12.968.2 19.0%  
Effective tax rate %15.011.4 130.7%   
Net profit margin %4.098.3 4.0%  
BALANCE SHEET DATA
Current assets Rs m5,373631 852.2%   
Current liabilities Rs m4,157170 2,452.4%   
Net working cap to sales %11.748.2 24.2%  
Current ratio x1.33.7 34.7%  
Inventory Days Days6851 133.0%  
Debtors Days Days7321 342.4%  
Net fixed assets Rs m6,244397 1,571.2%   
Share capital Rs m184261 70.7%   
"Free" reserves Rs m6,5664,000 164.1%   
Net worth Rs m6,7504,260 158.4%   
Long term debt Rs m1,233624 197.5%   
Total assets Rs m12,3635,203 237.6%  
Interest coverage x3.18.1 37.9%   
Debt to equity ratio x0.20.1 124.7%  
Sales to assets ratio x0.80.2 458.6%   
Return on assets %5.219.6 26.7%  
Return on equity %6.122.1 27.6%  
Return on capital %9.022.2 40.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,1430-   
Net fx Rs m2,6190-   
CASH FLOW
From Operations Rs m1,227-118 -1,038.2%  
From Investments Rs m-1,36048 -2,833.5%  
From Financial Activity Rs m-38849 -789.6%  
Net Cashflow Rs m-521-21 2,467.3%  

Share Holding

Indian Promoters % 59.2 56.5 104.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 3.6 347.2%  
FIIs % 6.0 3.6 166.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 36.3 61.7%  
Shareholders   12,805 4,078 314.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   BAJAJ FINANCE  TALWALKARS BETTER VALUE  INDIABULLS FIN. SER.  THOMAS COOK INDIA  WONDERLA HOLIDAYS  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CREST VENTURES Announces Quarterly Results (4QFY19); Net Profit Down 8.8% (Quarterly Result Update)

May 15, 2019 | Updated on May 15, 2019

For the quarter ended March 2019, CREST VENTURES has posted a net profit of Rs 103 m (down 8.8% YoY). Sales on the other hand came in at Rs 137 m (up 28.4% YoY). Read on for a complete analysis of CREST VENTURES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

CREST VENTURES Announces Quarterly Results (3QFY19); Net Profit Down 68.7% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, CREST VENTURES has posted a net profit of Rs 63 m (down 68.7% YoY). Sales on the other hand came in at Rs 133 m (down 25.9% YoY). Read on for a complete analysis of CREST VENTURES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Sep 20, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS